The impact of mid-wall striate of LGE at interventricular septum to the beta-broker (Carvedilol) titrating to the target dose and the improvement of cardiac function with DCM

It was reported that mid-wall striate late gadolinium enhancement at interventricular septum (MWS-LGE) definite by CMR was strong predictor of prognosis including sudden death with dilated cardiomyopathy (DCM). On the other hand, randomized trial have shown that beta-brokers lead symptomatic improvement, reduced hospitalization and enhanced survival in many patients with heart failure.